61996-32-5

Basic information

• Product Name: N-(5-Methyl-thiazol-2-yl)-acetaMide
• Synonyms: N-(5-Methyl-thiazol-2-yl)-acetaMide;2-AcetaMido-5-Methylthiazole
• CAS NO: 61996-32-5
• Molecular Formula: C6H8N2OS
• Molecular Weight: 156.20552
• Mol File: 61996-32-5.mol
• Article Data: 7

Chemical Properties

• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: /
• Density: 1.285g/cm³
• Refractive Index: 1.604
• Storage Temp.: Refrigerator
• Solubility: DMSO (Slightly), Methanol (Very Slightly, Heated)
• CAS DataBase Reference: N-(5-Methyl-thiazol-2-yl)-acetaMide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(5-Methyl-thiazol-2-yl)-acetaMide(61996-32-5)
• EPA Substance Registry System: N-(5-Methyl-thiazol-2-yl)-acetaMide(61996-32-5)

Safety Data

• Hazardous Substances Data: 61996-32-5(Hazardous Substances Data)

Usage

General Description

N-(5-Methyl-thiazol-2-yl)-acetamide, also known as Pantoprazole, is a medication used to treat conditions such as gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome. It belongs to a class of drugs called proton pump inhibitors (PPIs) and works by reducing the production of stomach acid. The chemical structure of N-(5-Methyl-thiazol-2-yl)-acetamide consists of a thiazole ring with a methyl group attached, as well as an amide functional group. N-(5-Methyl-thiazol-2-yl)-acetaMide is considered to be a key component in the formularies of pharmaceutical companies and is commonly used in the production of acid-reducing medications.

InChI:InChI=1/C6H8N2OS/c1-4-3-7-6(10-4)8-5(2)9/h3H,1-2H3,(H,7,8,9)

Upstream product

• 108-24-7 acetic anhydride 
• 7305-71-7 5-methyl-2-thiazol-2-amine 
• 75-36-5 acetyl chloride 
• 144836-46-4 1-bromo-1-nitropropan-2-one 

Relevant articles and documents

SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF THE ARYL HYDROCARBON RECEPTOR (AHR)

The present invention relates to bicyclic compounds which can act as aryl hydrocarbon receptor (AhR) modulators and, in particular, as AhR antagonists. The invention further relates to the use of the compounds for the treatment and/or prophylaxis of diseases and/or conditions through binding of said aryl hydrocarbon receptor by said compounds. A-B-L-C (I)

QUINOLINE DERIVATIVES

The invention concerns quinoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.

QUINOLINE DERIVATIVES FOR TREATING CANCER

The invention concerns quinoline derivatives of Formula (I) or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.